Cargando…

Side effects of drugs annual : a worldwide yearly survey of new data and trends. Volume 30 /

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical ye...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Dukes, M. N. G. (Maurice Nelson Graham), Beeley, Linda
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Elsevier, 2008.
Colección:Side effects of drugs annual ; 30
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front cover; Side Effects of Drugs Annual 30; Copyright page; Contributors; Contents; Special reviews; Cumulative indexes of special reviews, Annuals 13-29; Table of Essays, Annuals 1-29; DoTS classification of adverse drug reactions; How to use this book; Drug withdrawals because of adverse effects; Acknowledgement; References; Chapter 1. Central nervous system stimulants and drugs that suppress appetite; Amphetamines; Methylxanthines; Drugs that suppress appetite; Drugs used in Alzheimer's disease; References; Chapter 2. Antidepressant drugs; General; Tricyclic antidepressants
  • Selective serotonin re-uptake inhibitors (SSRIs)Serotonin and noradrenaline re-uptake inhibitors (SNRIs); Other antidepressants; References; Chapter 3. Lithium; The efficacy of lithium and comparisons with alternative agents; References; Chapter 4. Drugs of abuse; Cannabinoids; Cocaine; Fetotoxicity of cocaine; Epidemiology of the use of ecstasy; Khat; Opioid analgesics; References; Chapter 5. Hypnosedatives and anxiolytics; Benzodiazepines; Other hypnosedatives; References; Chapter 6. Antipsychotic drugs; General; Antipsychotic drugs in elderly patients; Individual drugs; References
  • Chapter 7. Antiepileptic drugsGeneral; Pregabalin; References; Chapter 8. Opioid analgesics and narcotic antagonists; Routes of administration of opioids; Opioid receptor agonists; Partial opioid receptor agonists; Opioid receptor antagonists; References; Chapter 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout; Strategies to reduce upper gastrointestinal tract damage caused by non-steroidal anti-inflammatory drugs (NSAIDs); Individual drugs and classes; Aniline derivatives; Paracetamol and the risk of asthma; COX-2 selective inhibitors; Oxicams; Pyrazolone derivatives
  • Drugs used in the treatment of goutReferences; Chapter 10. General anesthetics and therapeutic gases; Anesthetic Vapors; Halogenated vapors; Other vapors; Intravenous agents: non-barbiturate anesthetics; Prevention of pain due to propofol injection; Intravenous agents: barbiturate anesthetics; References; Chapter 11. Local anesthetics; Effects related to modes of use; Individual compounds; References; Chapter 12. Neuromuscular blocking agents and skeletal muscle relaxants; Depolarizing neuromuscular blocking agents; Skeletal muscle relaxants; References
  • Chapter 13. Drugs that affect autonomic functions or the extrapyramidal systemDrugs that stimulate both alpha- and beta-adrenoceptors; Drugs that predominantly stimulate alpha1-adrenoceptors; Drugs that stimulate beta1-adrenoceptors; Drugs that stimulate dopamine receptors; Pathological gambling and dopamine receptor agonists; Ergot derivatives; Drugs that affect the cholinergic system; References; Chapter 14. Dermatological drugs, topical agents, and cosmetics; Cosmetics; Phototherapy and photochemotherapy; Sunscreens; Vitamin A (retinoids); Vitamin D analogues, topical; References